Insulin degradation: Progress and potential

Endocrine Reviews

Volumn 19, Issue 5, 1998, Pages 608-624

  Duckworth, William C ^a,b,c   Bennett, Robert G ^a,b   Hamel, Frederick G ^a,b  

^a VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULINASE;

DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME INHIBITION; HORMONE ACTION; HORMONE INHIBITION; HORMONE RECEPTOR INTERACTION; INSULIN CLEARANCE; INSULIN DEGRADATION; INSULIN METABOLISM; LIPID METABOLISM; PRIORITY JOURNAL; PROTEIN DEGRADATION; REGULATORY MECHANISM; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; DIABETES MELLITUS; ENDOPEPTIDASES; HUMANS; INSULIN; INSULYSIN; KIDNEY; LIVER; MICE; MOLECULAR SEQUENCE DATA; OBESITY; PROTEIN DISULFIDE-ISOMERASE; RATS; RECEPTOR, INSULIN; SWINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031690490     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.19.5.608     Document Type: Review

References (237)

1. Duckworth WC, Kitabchi AE 1981 Insulin metabolism and degradation. Endocr Rev 2:210-233
2. Duckworth WC 1988 Insulin degradation: mechanisms, products, and significance. Endocr Rev 9:319-345
3. Duckworth WC, Bennett RG, Hamel FG 1997 The significance of intracellular insulin to insulin action. J Invest Med 45:20-27
4. Sonne O 1986 The reversible receptor binding of insulin in isolated rat adipocytes measured at 37 degrees: the binding is not rate limiting for cellular uptake. Biochim Biophys Acta 886:302-309
5. Canas X, Fernandez-Lopez JA, Ardevol A, Adan C, Esteve M, Rafecas I, Remesar X, Alemany M 1995 Rat insulin turnover in vivo. Endocrinology 136:3871-3876
6. Castillo MJ, Scheen AJ, Letiexhe MR, Lefebvre PJ 1994 How to measure insulin clearance. Diabetes Metab Rev 10:119-150
7. Morishima T, Pye S, Bradshaw C, Radziuk J 1992 Posthepatic rate of appearance of insulin: measurement and validation in the non-steady state. Am J Physiol 263:E772-E779
8. Hovorka R, Powrie JK, Smith GD, Sonksen PH, Carson ER, Jones RH 1993 Five-compartment model of insulin kinetics and its use to investigate action of chloroquine in NIDDM. Am J Physiol 265: E162-E175
9. Duckworth WC, Hamel FG, Insulin degradation and insulin degrading enzyme. In: Jefferson LS (ed) The Handbook of Physiology, The Endocrine Pancreas and Regulation of Metabolism. Oxford University Press, New York, in press
10. Sato H, Terasaki T, Mizuguchi H, Okumura K, Tsuji A 1991 Receptor-recycling model of clearance and distribution of insulin in the perfused mouse liver. Diabetologia 34:613-621
11. Duckworth WC, Hamel FG, Peavy DE 1988 Hepatic metabolism of insulin. Am J Med 85:71-76
12. Jochen A, Hays J, Lee M 1989 Kinetics of insulin internalization and processing in adipocytes: effects of insulin concentration. J Cell Physiol 141:527-534
13. Duckworth WC, Runyan K, Wright RK, Halban PA, Solomon SS 1981 Insulin degradation by hepatocytes in primary culture. Endocrinology 108:1142-1147
14. Benzi L, Cecchetti P, Ciccarone A, Pilo A, Di Cianni G, Navalesi R 1994 Insulin degradation in vitro and in vivo: a comparative study in men. Evidence that immunoprecipitable, partially rebindable degradation products are released from cells and circulate in blood. Diabetes 43:297-304
15. Wahlqvist ML, Kaijser L, Lassers BW, Low H, Carlson LA 1972 Release of immunoreactive insulin from the human heart. Eur J Clin Invest 2:407-411
16. Hennes MM, Dua A, Kissebah AH 1997 Effects of free fatty acids and glucose on splanchnic insulin dynamics. Diabetes 46:57-62
17. Pagano C, Rizzato M, Lombardi AM, Fabris R, Favaro A, Federspil G, Vettor R 1996 Effect of lactate on hepatic insulin clearance in perfused rat liver. Am J Physiol 270:R682-R687
18. Svedberg J, Bjorntorp P, Smith U, Lonnroth P 1990 Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes 39:570-574
19. Boden G 1997 Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3-10
20. Bonora E, Zavaroni I, Coscelli C, Butturini U 1983 Decreased hepatic insulin extraction in subjects with mild glucose interolerance. Metabolism 32:438-446
21. Bonora E, Zavaroni I, Manicardi V, Coscelli C, Butturini U 1986 Further evidence that insulin metabolism is a major determinant of peripheral insulin response to oral glucose in subjects with mild glucose intolerance. J Endocrinol Invest 9:371-374
22. 3H insulin in streptozotocin diabetic rats: role of the insulin-receptor compartment. J Clin Invest 67:673-680
23. Jones CN, Pei D, Staris P, Polonsky KS, Chen YD, Reaven GM 1997 Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals. J Clin Endocrinol Metab 82:1834-1838
24. Trischitta V, Brunetti A, Chiavetta A, Benzi L, Papa V, Vigneri R 1989 Defects in insulin-receptor internalization and processing in monocytes of obese subjects and obese NIDDM patients. Diabetes 38:1579-1584
25. Okuda Y, Pena J, Chou J, Field JB 1994 Effect of growth hormone on hepatic glucose and insulin metabolism after oral glucose in conscious dogs. Am J Physiol 267:E454-E460
26. Monti LD, Brambilla P, Caumo A, Magni F, Omati S, Nizzoli G, di Natale B, Galli-Kiente M, Cobelli C, Chiumello G, Pozza G 1997 Glucose turnover and insulin clearance after growth hormone treatment in girls with Turner's syndrome. Metabolism 46:1482-1488
27. Evans DJ, Hoffman RG, Kalkhoff RK, Kissebah AH 1984 Relationship of body fat topography to insulin sensitivity and metabolic profiles of premenopausal women. Metabolism 33:68-75
28. Peiris AN, Mueller RA, Strove MF, Smith GA, Kissebah AH 1987 Relationship of androgenic activity to splanchnic insulin metabolism and peripheral glucose utilization in premenopausal women. J Clin Endocrinol Metab 64:162-169
29. Peiris AN, Mueller RA, Strove MF, Smith GA, Kissebah AH 1986 Splanchnic insulin metabolism in obesity: influence of body fat distribution. J Clin Invest 78:1648-1657
30. Krakover GR, Meier DA, Kissebah AH 1993 Female sex hormones, perinatal, and peripubertal androgenization on hepatocyte insulin dynamics in rats. Am J Physiol 264:E342-E347
31. Mondon CE, Reaven GM, Azhar S, Lee CM, Rabkin R 1989 Abnormal insulin metabolism by specific organs from rats with spontaneous hypertension. Am J Physiol 257:E491-E498
32. Caro JF, Amatruda JM 1980 Functional relationships between insulin binding, action, and degradation. A reassessment. J Biol Chem 255:10052-10055
33. Caro JF, Amatruda JM 1981 Evidence for modulation of insulin action and degradation independently of insulin binding. Am J Physiol 240:E325-E332
34. Groop L, Luzi L, Melander A, Groop PH, Ratheiser K, Simonson DC, DeFronzo RA 1987 Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects. Diabetes 36:1320-1328
35. Chen H, Hamel FG, Silford GL, Duckworth WC 1993 Alteration of rat hepatic insulin metabolism by glyburide and glipizide. J Pharmacol Exp Ther 264:1293-1298
36. Adrogue HJ, Pena J, Comstrock JP 1996 Glyburide increases the secretion, tissue uptake, and action of insulin in conscious normal dogs. Metabolism 45:579-586
37. Auletta M, Antoniello S, Abrescia N 1994 Insulin-degrading activity in experimental liver cirrhosis of the rat. Enzyme Protein 95:197-201
38. Letiexhe MR, Scheen AJ, Gerard PL, Easterns BH, Pirotte J, Belaiche J, Lefebvre PJ 1993 Insulin secretion, clearance, and action on glucose metabolism in cirrhotic patients. J Clin Endocrinol Metab 77:1263-1268
39. Antoniello S, La Rocca S, Cavalcanti E, Auletta M, Salvatore F, Cacciatore L 1989 Insulin and glucagon degradation in liver are not affected by hepatic cirrhosis. Clin Chim Acta 183:343-350
40. Harada S, Loten EG, Smith RM, Harett L 1992 Nonreceptor mediated nuclear accumulation of insulin in H35 rat hepatoma cells. J Cell Physiol 153:607-613
41. Petruzzelli L, Herrera R, Garcia-Arenas R, Rosen OM 1985 Acquisition of insulin-dependent protein tyrosine kinase activity during Drosophila embryogenesis. J Biol Chem 260:16072-16075
42. Rabkin R, Kitaji J 1983 Renal metabolism of peptide hormones. Miner Electrolyte Metab 9:212-226
43. Rabkin R, Ryan MP, Duckworth WC 1984 Renal metabolism of insulin. Diabetologia 27:351-357
44. Kruse V, Jensen I, Permin L, Heding A 1497 Fate of insulin analogs in intact and nephrectomized rats determined by their receptor binding constants. Am J Physiol 272:E1089-E1098
45. Hysing J, Tolleshaug H, Kindberg GM 1989 Renal Uptake and degradation of trapped-label insulin. Renal Physiol Biochem 12: 228-237
46. Nielsen S 1992 Time course and kinetics of proximal tubular processing of insulin. Am J Physiol 262:F813-F822
47. Fawcett J, Rabkin R 1993 Degradation of insulin by isolated rat renal cortical endosomes. Endocrinology 133:1539-1547
48. 125I-insulin by the nonfiltering perfused rat kidney. Biochim Biophys Acta 1073:442-450
49. Fawcett J, Rabkin R 1995 Sequential processing of insulin by cultured kidney cells. Endocrinology 136:39-45
50. 14C] sucrose-insulin in perfused rat livers. Am J Physiol 255:C70-C75
51. Dahl DC, Tsao T, Duckworth WC, Mahoney MJ, Rabkin R 1989 Retroendocytosis of insulin in a cultured kidney epithelial cell line. Am J Physiol 257:C190-C196
52. Dahl DC, Tsao T, Duckworth WC, Frank BH, Rabkin R 1990 Effect of bacitracin on the retroendocytosis and degradation of insulin in cultured kidney epithelial cell line. Diabetes 39:1339-1346
53. de Vries CP, Van Haeften TW, Rao BR, Van Der Veen EA 1990 Effect of the insulin degradation inhibitors bacitracin and chloroquine on insulin binding data to H35 rat hepatoma cells. Diabete Metab 16:70-76
54. Medina V, Kesner L, Stracher A 1993 Purification of nonantibiotic insulinase inhibitors from bacitracin. Biochem Med Metab Biol 49:255-264
55. Heckmeyer C, Solomon SS, Barker J, Duckworth WC 1982 Selective antilipolytic effect of bacitracin in the isolated fat cell. Biochem Biophys Res Commun 108:336-343
56. Rabkin R, Unterhalter SA, Duckworth WC 1979 Effect of prolonged uremia on insulin metabolism by isolated liver and muscle. Kidney Int 16:433-439
57. Duckworth WC, Gifford D, Kirabchi AE, Runyan K, Solomon SS 1979 Insulin binding and degradation by muscles from streptozotocin-diabetic rats. Diabetes 28:414-417
58. Jochen A, Berhanu P 1987 Effects of metalloendoprotease inhibitors on insulin binding, internalization and processing in adipocytes. Biochem Biophys Res Commun 142:205-212
59. Ardevol A, Adan C, Canas X, Rafecas I, Mesteve M, Remesar X, Fernandez-Lopez JA, Alemany M 1996 Adipose tissue extraction of circulating insulin in anaesthetized Zucker obese rats. Int J Obes 20:837-841
60. Baldwin Jr D, Prince M, Tsai P, Johnson C, Lotan R, Rubenstein AH, Olefsky JM 1981 Insulin binding, internalization, and receptor regulation in cultured human fibroblasts. Am J Physiol 241:E251-E260
61. Stentz FB, Harris HL, Kitabchi AE 1985 Characterization of insulin-degrading activity of intact and subcellular components of human fibroblasts. Endocrinology 116:926-934
62. Powers AC, Solomon SS, Duckworth WC 1980 Insulin degradation by mononuclear cells. Diabetes 29:27-32
63. Buffington CK, el-Shiekh T, Kitabchi AE, Matteri R 1986 Phytohemagglutinin (PHA) activated human T lymphocytes: concomitant appearance of insulin binding, degradation, and insulin mediated activation of pyruvate dehydrogenase. Biochem Biophys Res Commun 134:412-419
64. Bai JP, Hsu MJ, Shier WT 1995 Insulin-degrading enzyme in a human colon adenocarcinoma cell line (Caco-2). Pharm Res 12: 513-516
65. Huber CT, Solomon SS, Duckworth WC 1980 The time course of insulin degradation in the perifused isolated fat cell. J Clin Invest 65:461-468
66. Shearer JD, Coulter CF, Engeland WC, Roth RA, Caldwell MD 1997 Insulin is degraded extracellularly in wounds by insulin-degrading enzyme (EC 3.4.24.56). Am J Physiol 273:E657-E664
67. Hamel FG, Peavy DE, Ryan MP, Duckworth WC 1987 High performance liquid chromatographic analysis of insulin degradation products from isolated hepatocytes: effects of inhibitors suggest intracellular and extracellular pathways. Diabetes 36:702-708
68. Jochen AL, Berhanu P 1987 Insulin-stimulated glucose transport and insulin internalization share a common postbinding step in adipocytes. Diabetes 36:542-545
69. 2-macroglobulin and insulin correlate with separate routes of ligand-receptor complex internalization. Endocrinology 126:1551-1560
70. Backer JM, Kahn CR, White MF 1990 The dissociation and degradation of internalized insulin occur in the endosomes of rat hepatoma cells. J Biol Chem 265:14828-14835
71. Harada S, Smith RM, Smith JA, Jarett L 1993 Inhibition of insulin-degrading enzyme increases translocation of insulin to the nucleus in H35 rat hepatoma cells: evidence of a cytosolic pathway. Endocrinology 132:2293-2298
72. Soler AP, Thompson KA, Smith RM, Jarett L 1989 Immunological demonstration of the accumulation of insulin, but not insulin receptors, in nuclei of insulin-treated cells. Proc Natl Acad Sci USA 86:6640-6644
73. Smith RM, Jarett L 1987 Ultrastructural evidence for the accumulation of insulin in nuclei of intact 3T3-L1 adipocytes by an insulin-receptor mediated process. Proc Natl Acad Sci USA 84:459-463
74. Thompson KA, Soler AP, Smith RM, Jarett L 1989 Intranuclear localization of insulin in rat hepatoma cells: insulin/matrix association. Eur J Cell Biol 50:442-446
75. Smith RM, Jarett L 1990 Partial characterization of mechanism of insulin accumulation in H35 hepatoma cell nuclei. Diabetes 39: 683-689
76. Harada S, Smith RM, Smith JA, Shah N, Jarett L 1995 Demonstration of specific insulin binding to cytosolic proteins in H35 hepatoma cells, rat liver and skeletal muscle. Biochem J 306:21-28
77. 125I iodoinsulin entry into adult rat hepatocytes in vivo: evidence for multiple sites of hormone localization. Endocrinology 108:1821-1828
78. Smith RM, Jarett L 1989 Biology of disease. Receptor-mediated endocytosis and intracellular processing of insulin: ultrastructural and biochemical evidence for cell-specific heterogeneity and distinction from nonhormonal ligands. In: Rubin E, Damjanov I (eds) Pathology Reviews. Humana Press Inc., Clifton, NJ, pp 37-53
79. Levy J, Olefsky JM 1987 The effect of insulin concentration on retroendocytosis in isolated rat adipocytes. Endocrinology 120: 450-456
80. Yonezawa K, Yokono K, Shii K, Hari J, Yaso S, Amano K, Sakamoto T, Kawase Y, Akiyama H, Nagata M, Baba S 1988 Insulin-degrading enzyme is capable of degrading receptor-bound Insulin. Biochem Biophys Res Commun 150:605-614
81. Seta KA, Roth RA 1997 Overexpression of insulin degrading enzyme: cellular localization and effects on insulin signaling. Biochem Biophys Res Commun 231:167-171
82. Pell ME, Duckworth WC, Peavy DE 1986 Localization of insulin degradation products to an intracellular site in isolated rat hepatocytes. Biochem Biophys Res Commun 137:1034-1040
83. Clot JP, Janicot M, Fouque F, Desbuquois B, Haumont PY, Lederer F 1990 Characterization of insulin degradation products generated in liver endosomes: in vivo and in vitro studies. Mol Cell Endocrinol 72:175-185
84. Berhanu P 1988 Internalized insulin-receptor complexes are unidirectionally translocated to chloroquine-sensitive degradative sites. J Biol Chem 263:5961-5969
85. Backer JM, Kahn CR, Cahill DA, Ullrich A, White MF 1990 Receptor-mediated internalization of insulin requires a 12-amino acid sequence in the juxtamembrane region of the insulin receptor beta-subunit. J Biol Chem 265:16450-16454
86. Hari J, Roth RA 1987 Defective internalization of insulin and its receptor in cells expressing mutated insulin receptors lacking kinase activity. J Biol Chem 262:15341-15344
87. Carpentier JL, Paccaud PP, Backer JM, Gilbert A, Orci L, Kahn CR 1993 Two steps of insulin receptor internalization depend on different domains of the beta-subunit. J Cell Biol 122:1243-1252
88. Calzi SL, Choice CV, Najjar SM 1997 Differential effect of pp120 on insulin endocytosis by two variant insulin receptor isoforms. Am J Physiol 273:E801-E808
89. McClain DA 1991 Different ligand affinities of the two human insulin receptor splice variants are reflected in parallel changes in sensitivity for insulin action. Mol Endocrinol 5:734-739
90. Yamaguchi Y, Flier JS, Yokota A, Benecke H, Backer JM, Moller DE 1991 Functional properties of two naturally occurring isoforms of the human insulin receptor in Chinese hamster ovary cells. Endocrinology 129:2058-2066
91. Hamel FG, Mahoney MJ, Duckworth WC 1991 Degradation of intraendosomal insulin by insulin degrading enzyme without acidification. Diabetes 40:436-443
92. Hamel FG, Posner BI, Bergeron JJM, Frank BH, Duckworth WC 1988 Isolation of insulin degradation products from endosomes derived from intact rat liver. J Biol Chem 263:6703-6708
93. Duckworth WC, Hamel FG 1990 Cellular and endosomal degradation. In: Nishizuka Y, Endok M, Tanaka C (eds) The Biology and Medicine of Signal Transduction. Raven Press, New York, pp 521-528
94. 125I]-insulin metabolism by the rat liver in vivo: evidence that a neutral thiol-protease mediates rapid intracellular insulin degradation. Metabolism 39: 231-241
95. Authier F, Rachubinski RA, Posner BI, Bergeron JJM 1994 Endosomal proteolysis of insulin by an acidic thiol metalloprotease unrelated to insulin degrading enzyme. J Biol Chem 269:3010-3016
96. Seabright PJ, Smith GD 1996 The characterization of endosomal insulin degradation intermediates and their sequence of production. Biochem J 320:947-956
97. Authier F, Cameron PH, Taupin V 1996 Association of insulin-degrading enzyme with a 70 kDa cytosolic protein in hepatoma cells. Biochem J 319:149-158
98. 125I insulin with a cytosolic insulin-degrading enzyme: detection by covalent cross-linking and immuno-precipitation with a monoclonal antibody. Endocrinology 120:829-831
99. Akiyama H, Yokono K, Shii K, Ogawa W, Taniguchi H, Baba S, Kasuga M 1990 Natural regulatory mechanisms of insulin degradation by insulin degrading enzyme. Biochem Biophys Res Commun 170:1325-1330
100. Harada S, Smith RM, Jarett L 1994 1,10-Phenanthroline increases nuclear accumulation of insulin in response to inhibiting insulin degradation but has a biphasic effect on insulin's ability to increase mRNA levels. DNA Cell Biol 13:487-493
101. Davies JG, Muir AV, Offord RE 1986 Identification of some cleavage sites of insulin by insulin proteinase. Biochem J 240:609-612
102. B1 insulin. Biochem J 249:209-214
103. Duckworth WC, Garcia JV, Liepnieks JJ, Hamel FG, Hermodson MA, Rosner MR 1989 Drosophila insulin degrading enzyme and rat skeletal muscle insulin protease cleave insulin at similar sites. Biochemistry 28:2471-2477
104. Duckworth W, Hamel F, Liepnieks J, Frank B, Yagil C, Rabkin R 1988 High performance liquid chromatographic analysis of insulin degradation products from a cultured kidney cell line. Endocrinology 123:2701-2708
105. Duckworth WC, Hamel FG, Liepnieks JJ, Peavy DE, Ryan MP, Hermodson MA, Frank BH 1987 Identification of A chain cleavage sites in intact insulin produced by insulin protease and isolated hepatocytes. Biochem Biophys Res Commun 147:615-621
106. Duckworth WC, Hamel FG, Liepnieks JJ, Peavy DE, Frank BH, Rabkin R 1989 High performance liquid chromatographic analysis of insulin degradation products from perfused rat kidney. Am J Physiol 256:E208-E214
107. Duckworth WC, Hamel FG, Peavy DE, Liepnieks JJ, Ryan MP, Hermodson MA, Frank BH 1988 Degradation products of insulin generated by hepatocytes and by insulin protease. J Biol Chem 263:1826-1833
108. Duckworth WC, Stentz FB, Heinemann MA, Kitabchi AE 1974 Initial site of cleavage of insulin by insulin protease. Proc Nat Acad Sci USA 76:635-639
109. Hamel FG, Peavy DE, Ryan MP, Duckworth WC 1986 High performance liquid chromatographic analysis of insulin degradation by rat skeletal muscle insulin protease. Endocrinology 118:328-333
110. 125I]monoiodoinsulin. Diabetes 38:152-157
111. Savoy LA, Jones RM, Pochon S, Davies JG, Muir AV, Offord RE, Rose K 1988 Identification by fast atom bombardment mass spectrometry of insulin fragments produced by insulin proteinase. Biochem J 249:215-222
112. Stentz FB, Kitabchi A, Schilling JW, Schronk LR, Seyer JM 1989 Identification of insulin intermediates and sites of cleavage of native insulin by insulin protease from human fibroblasts. J Biol Chem 264:20275-20282
113. Muller D, Schulze C, Baumeister H, Buck F, Richter D 1992 Rat insulin-degrading enzyme: cleavage pattern of the natriuretic peptide hormones ANP, BNP and CNP revealed by HPLC and mass spectrometry. Biochemistry 31:11138-11143
114. Ryan MP, Duckworth WC 1988 Insulin degradation: assays and enzymes. In: Kahn C, Harrison L (eds) The Insulin Receptor. Alan R. Liss, Inc., New York, vol 1:29-57
115. Frank BH, Peavy DE, Hooker CS, Duckworth WC 1983 Receptor binding properties of monoiodotyrosyl insulin isomers purified by high performance liquid chromatography. Diabetes 32:705-711
116. Ryan MP, Peavy DE, Frank BH, Duckworth WC 1984 The degradation of monoiodotyrosyl insulin isomers by insulin protease. Endocrinology 115:591-599
117. Mirsky IA, Broh-Kahn RH 1949 The inactivation of insulin bytissue extracts. I. The distribution and properties of insulin inactivating extracts (insulinase). Arch Biochem 20:1-9
118. Ryan MP, Gifford JD, Solomon SS, Duckworth WC 1985 The calcium dependence of insulin degradation by rat skeletal muscle. Endocrinology 117:1693-1698
119. 125I insulin to a cytosolic insulin degrading enzyme. J Biol Chem 260: 6503-6506
120. Shii K, Roth RA 1986 Inhibition of insulin degradation by hepatoma cells after microinjections of monoclonal antibodies to a specific cytosolic protease. Proc Nat Acad Sci USA 83:4147-4151
121. Kuo WL, Gehm BD, Rosner MR 1991 Regulation of insulin degradation: expression of an evolutionary conserved insulin-degrading enzyme increases degradation via an intracellular pathway. Mol Endocrinol 5:1467-1476
122. Duckworth WC 1994 Editorial: Increasing understanding of calmodulin-insulin interactions. J Lab Clin Med 124:311-312
123. Affholter JA, Fried VA, Roth RA 1988 Human insulin-degrading enzyme shares structural and functional homologies with E. coli protease III. Science 242:1415-1418
124. Becker AB, Roth RA 1995 Insulysin and pitrilysin: insulin-degrading enzymes of mammals and bacteria. Methods Enzymol 248: 693-703
125. Duckworth WC, Hamel FG, Bennett RG, Ryan MP, Roth RA 1990 Human red blood cell insulin-degrading enzyme and rat skeletal muscle insulin protease share antigenic sites and generate identical products from insulin. J Biol Chem 265:2984-2987
126. Ebrahim A, Hamel FG, Bennett RG, Duckworth WC 1991 Identification of the metal associated with the insulin degrading enzyme. Biochem Biophys Res Commun 181:1398-1406
127. Ansorge S, Bohley PL, Kirschke J, Langner J, Wiederanders B 1984 The insulin and glucagon degrading proteinase of rat liver: a metal dependent enzyme. Biomed Biochim Acta 43:39-46
128. Perlman RK, Gehm BD, Kuo WL, Rosner MR 1993 Functional analysis of conserved residues in the active site of insulin-degrading enzyme. J Biol Chem 268:21538-21544
129. Becker AB, Roth RA 1992 An unusual active site identified in a family of zinc metalloendopeptidases. Proc Natl Acad Sci USA 89:3835-3839
130. Becker AB, Roth RA 1993 Identification of glutamate-169 as the third zinc-binding residue in proteinase III, a member of the family of insulin-degrading enzymes. Biochem J 292:137-142
131. Gehm BD, Kuo WL, Periman RK, Rosner MR 1993 Mutations in a zinc-binding domain of human insulin-degrading enzyme eliminate catalytic activity but not insulin binding. J Biol Chem 268: 7943-7948
132. Ryan MP, Duckworth WC 1983 Partial characterization of an endogenous inhibitor of a calcium-dependent form of insulin protease. Biochem Biophys Res Commun 116:195-203
133. Authier F, Posner BI, Bergeron JJM 1996 Insulin-degrading enzyme. Clin Invest Med 19:149-160
134. Dykstra CC, Kushner SR 1985 Physical characterization of the cloned protease III gene from Escherichia coli K-12. J Bacteriol 163: 1055-1059
135. Cheng YE, Zipser D 1979 Purification and characterization of protease III from Escherichia coli. J Biol Chem 254:4698-4706
136. Ding L, Becker AB, Suzuki A, Roth RA 1992 Comparison of the enzymatic and biochemical properties of human insulin-degrading enzyme and Escherichia coli protease III. J Biol Chem 267:2414-2420
137. Rawlings ND, Barrett AJ 1993 Evolutionary families of peptidases. Biochem J 290:205-218
138. Rawlings ND, Barrett AJ 1991 Homologues of insulinase, a new superfamily of metalloendopeptidases. Biochem J 275:389-391
139. Periman RK, Rosner MR 1994 Identification of zinc ligands of the insulin-degrading enzyme. J Biol Chem 269:33140-33145
140. Affholter JA, Casciere MA, Bayne ML, Brange J, Casaretto M, Roth RA 1990 Identification of residues in the insulin molecule important for binding to insulin-degrading enzyme. Biochemistry 29:7727-7733
141. Kole HK, Muthukumar G, Lenard J 1991 Purification and properties of a membrane-bound insulin binding protein, a putative receptor, from Neurospora crassa. Biochemistry 30:682-688
142. Kole HK, Smith DR, Lenard J 1992 Characterization and partial purification of an insulinase from Neurospora crassa. Arch Biochem Biophys 297:199-204
143. Fricke B, Betz R, Friebe S 1995 A periplasmic insulin-cleaving proteinase (ICP) from Acinetobacter calcoaceticus sharing properties with protease III from Escherichia coli and IDF from eucaryotes. J Basic Microbiol 35:21-31
144. Affholter JA, Hsieh CL, Francke U, Roth RA 1990 Insulin-degrading enzyme: stable expression of the human complementary DNA, characterization of its protein product, and chromosomal mapping of the human and mouse genes. Mol Endocrinol 4:1125-1135
145. Bondy CA, Zhou J, Chin E, Reinhardt RR, Roth RA 1994 Cellular distribution of insulin-degrading enzyme gene expression: comparison with insulin and insulin-like growth factor receptors. J Clin Invest 93:966-973
146. Kuo WL, Montag AG, Rosner MR 1993 Insulin-degrading enzyme is differentially expressed and developmentally regulated in various rat tissues. Endocrinology 132:604-611
147. Kuo WL, Gehm BD, Rosner MR, Li W, Keller G 1994 Inducible expression and cellular localization of insulin-degrading enzyme in a stably transfected cell line. J Biol Chem 269:22599-22606
148. Baumeister H, Muller D, Rehbein M, Richter D 1993 The rat insulin degrading enzyme: molecular cloning and characterization of tissue-specific transcripts. FEBS Lett 317:250-254
149. Ogawa W, Shii K, Yonezawa K, Baba S, Yokono K 1992 Affinity purification of insulin-degrading enzyme and its endogenous inhibitor from rat liver. J Biol Chem 267:1310-1316
150. McKenzie RA, Burghen GA 1984 Partial purification and characterization of insulin protease and its inrracellular inhibitor from rat liver. Arch Biochem Biophys 229:604-611
151. Misbin RI, Almira EC, Cleman MW 1981 Insulin degradation in serum of a patient with apparent insulin resistance. J Clin Endocrinol Metab 52:177-180
152. Bennett RG, Hamel FG, Duckworth WC 1994 Identification and isolation of a cytosolic proteolytic complex containing insulin degrading enzyme and the multicatalytic proteinase. Biochem Biophys Res Commun 202:1047-1053
153. Duckworth WC 1978 Insulin and glucagon binding and degradation by the kidney cell membrane. Endocrinology 102:1766-1774
154. Duckworth WC 1979 Insulin degradation by liver cell membranes. Endocrinology 104:1758-1764
155. Yokono K, Imamura Y, Sakai H, Baba S 1979 Insulin-degrading activity of plasma membranes from rat skeletal muscle: its isolation, characterization, and biologic significance. Diabetes 28:810-817
156. Yokono K, Roth RA, Baba S 1982 Identification of insulin-degrading enzyme on the surface of cultured human lymphocytes, rat hepatoma cells, and primary cultures of rat hepatocytes. Endocrinology 111:1102-1108
157. Goldfine ID, Williams JA, Bailey AC, Wong KY, Iwamoto Y, Yokono K, Baba S, Rother RA 1984 Degradation of insulin by isolated mouse pancreatic acini: evidence for cell surface protease activity. Diabetes 33:64-72
158. Authier F, Bergeron JJ, Ou WJ, Rachubinski RA, Posner BI, Walton PA 1995 Degradation of the cleaved leader peptide of thiolase by a peroxisomal proteinase. Proc Natl Acad Sci USA 92:3859-3863
159. Rabkin R, Birn H, Shi J, Roth R, Christensen E 1992 Insulin degrading enzyme (IDE) in renal proximal tubules. Diabetes 41: 15A
160. Chesneau V, Perlman RK, Li W, Keller GA, Rosner MR 1997 Insulin-degrading enzyme does not require peroxisomal localization for insulin degradation. Endocrinology 138:3444-3451
161. Duckworth WC, Kitabchi AE 1974 Insulin and glucagon degradation by the same enzyme. Diabetes 23:536-543
162. Gehm BD, Rosner MR 1991Regulation of insulin, epidermal growth factor, and transforming growth factor-α levels by growth factor degrading enzymes. Endocrinology 128:1603-1609
163. Roth RA, Mesirow ML, Yokono K, Baba S 1984 Degradation of insulin-like growth factors I and II by a human insulin degrading enzyme. Endocr Res 10:101-112
164. Burghen GA, Duckworth WC, Kitabchi AE, Solomon SS, Poffenbarger PL 1976 Inhibition of insulin degradation by nonsuppressible insulin-like activity. J Clin Invest 57:1089-1093
165. Muller D, Baumeister H, Buck F, Richter D 1991 Atrial natriuretic peptide (ANP) is a high-affinity substrate for rat insulin-degrading enzyme. Eur J Biochem 202:285-292
166. Hamel FG, Gehm BD, Rosner RG, Duckworth WC 1997 Identification of the cleavage sites of transforming growth factor-alpha by insulin degrading enzymes. Biochim Biophys Acta 1338:207-214
167. Kitabchi AE, Duckworth WC, Brush JS, Heinemann M 1971 Direct measurement of proinsulin in human plasma by the use of an insulin degrading enzyme. J Clin Invest 50:1792-1799
168. Misbin RI, Almira EC, Duckworth WC, Mehl TD 1983 Inhibition of insulin degradation by insulin-like growth factors. Endocrinology 113:1525-1527
169. Baskin FK, Kitabchi AE 1973 Substrate studies for insulin specific protease. Eur J Biochem 37:489-496
170. Garcia JV, Fenton BW, Rosner MR 1988 Isolation and characterization of an insulin-degrading enzyme from Drosophila melanogaster. Biochemistry 27:4237-4244
171. Thompson KL, Decker SJ, Rosner MR 1985 Identification of a novel receptor in Drosophila for both epidermal growth factor and insulin. Proc Natl Acad Sci USA 82:8443-8447
172. Garcia JV, Stoppelli MP, Thompson KL, Decker SJ, Rosner MR 1987 Characterization of a Drosophila protein that binds both epidermal growth factor and insulin-related growth factors. J Cell Biol 105:449-456
173. Garcia JV, Stopelli MP, Decker SJ, Rosner MR 1989 An insulin epidermal growth factor-binding protein from Drosophila has insulin-degrading activity. J Cell Biol 108:177-182
174. Fagan JM, Waxman L 1991 Purification of a protease in red blood cells that degrades oxidatively damaged haemoglobin. Biochem J 277:779-786
175. Safavi A, Miller BC, Cottam L, Hersh LB 1996 Identification of y endorphin-generating enzyme as insulin-degrading enzyme. Biochemistry 35:14318-14325
176. Kurochkin IV, Goto S 1994 Alzheimer's β-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett 345:33-37
177. Hamel FG, Siford GL, Jones J, Duckworth WC 1997 Intraendosomal degradation of transforming growth factor alpha. Mol Cell Endocrinol 126:185-192
178. McDermott JR, Gibson AM 1997 Degradation of Alzheimer's β-amy loid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme. Neurochem Res 22:49-56
179. Peavy DE, Brunner MR, Duckworth WC, Hooker CS, Frank BH 1985 Receptor binding and biological potency of several split forms (conversion intermediates) of human proinsulin: studies in cultured IM-9 lymphocytes and in vitro in rats. J Biol Chem 260:13989-13994
180. Faulsen EP, Courtney JW, Duckworth WC 1979 Insulin resistance due to massive destruction of subcutaneous insulin. Diabetes 28: 640-645
181. Schade DS, Duckworth WC 1986 In search of the subcutaneous insulin degradation syndrome. N Engl J Med 315:147-153
182. Schade DS, Drumm DA, Duckworth WC, Eaton RP 1985 The etiology of incapacitating brittle diabetes. Diabetes Care 8:18-20
183. Schade DS, Eaton RP, Drumm DA, Duckworth WC 1985 A clinical algorithm to determine the etiology of brittle diabetes. Diabetes Care 8:5-11
184. Lau PP, Van Handel M, Larvin M, McMahon MJ, Geokas MC 1990 Proteolytic degradation of human recombinant proinsulin/ insulin by sera from acute pancreatitis patients and complete inhibition by Eglin-C. Pancreas 5:17-26
185. Stoppelli MP, Garcia JV, Decker SJ, Rosner MR 1988 Developmental regulation of an insulin degrading enzyme from Drosophila melanogaster. Proc Natl Acad Sci USA 85:3469-3473
186. 3H1 and primary skeletal muscle cells and the activity of their endogenous insulin-degrading enzyme are inhibited by the same metalloendoprotease inhibitors. J Cell Biochem 44:137-151
187. Naquet P, Ellis J, Singh B, Hodges RS, Delovitch TL 1987 Processing and presentation of insulin. I. Analysis of immunogenic peptides and processing requirements for insulin. A loop-specific T cells. J Immunol 139:3955-3963
188. Semple J, Ellis J, Delovitch T 1989 Processing and presentation of insulin. II. Evidence for intracellular, plasma membrane-associated and extracellular degradation of human insulin by antigen presenting B cells. J Immunol 142:4184-4193
189. Delovitch T, Semple W, Naquet P, Bernard N, Ellis J, Champagne P, Phillips M 1988 Pathways of processing of insulin by antigen-presenting cells. Immunol Rev 106:195-222
190. Semple JW, Lang Y, Speck ER, Delovitch TL 1992 Processing and presentation of insulin. III. Insulin degrading enzyme: a neutral metalloendoproteinase that is non-homologous to classical endoproteinases mediates the processing of insulin epitopes for helper T cells. Int Immunol 4:1161-1167
191. Wegmann DR, Gill RG, Norbury-Glaser M, Schloot N, Daniel D 1994 Analysis of the spontaneous T cell response to insulin in NOD mice. J Autoimmun 7:833-843
192. Daniel D, Gill RG, Schloot N, Wegmann DR 1995 Epitope specificity, cytokine production profile and diabetogeneic activity of insulin-specific T cell clones isolated from NOD mice. Eur J Immunol 25:1056-1062
193. Crawford M, Daniel D, Wegmann DR, Yang H, Gill RG 1997 Autoimmune islet damage mediated by insulin-specific T cells. Transplant Proc 29:758-759
194. Daniel D, Wegmann DR 1996 Protection of nonobese diabetic mice from diabetes by intranasal of subcutaneous administration of insulin peptide B-(9-23). Proc Natl Acad Sci USA 93:956-960
195. Fujita A, Oka C, Arikawa Y, Katagal T, Tonouchi A, Kuhara S, Misumi Y 1994 A yeast gene necessary for bud-site selection encodes a protein similar to insulin-degrading enzymes. Nature 372: 567-570
196. Adames N, Blandell K, Ashby MN, Boone C 1995 Role of yeast insulin-degrading enzyme homologs in propherotnone processing and bud site selection. Science 270:464-467
197. Pierotti AR, Prat A, Chesneau V, Gaudoux F, Leseney AM, Foulon T, Cohen P1994 N-Arginine dibasic convertase, a metalloendopeptidase as a prototype of a class of processing enzymes. Proc Natl Acad Sci USA 91:6078-6082
198. Blache P, Kervran A, Duckworth WC, Bataille D 1992 Purification and partial characterization of the liver membrane endopeptidase which transforms glucagon into glucagon (19-29). Biomed Res 13:51-55
199. Mallat A, Pavoine C, Dufour M, Lotersztajn S, Bataille D, Pecker F 1987 A glucagon fragment is responsible for the inhibition of the liver Ca2+ pump by glucagon. Nature 325:620-622
200. Blache P, Kervran A, Le-Nguyen D, Dufour M, Cohen-Sodal A, Duckworth W, Bataille D 1993 Endopeptidase from rat liver membranes, which generates miniglucagon from glucagon. J Biol Chem 268:21748-21753
201. Varandani PT, Shroyer LA, Nafz MA 1972 Sequential degradation of insulin by rat liver homogenates. Proc Natl Acad Sci USA 69: 1681-1684
202. Varandani PT 1980 Role of the biodegradation process in the action of insulin. A proposal for a model consisting of sulfhydryl-disulfide interchange reacter and proteolysis. In: Brandenburg D, Wollmer A (eds) Insulin, Chemistry, Structure and Function of Insulin and Related Hormones. Walter de Grayter, Berlin, pp 475-482
203. Kaderbhai MA, Austen BM 1985 Studies on the formation of interchain disulfide bonds in newly synthesized bovine prolactin. Eur J Biochem 153:167-178
204. Roth RA, Koshland ME 1981 Role of disulfide interchange enzyme in immunoglobulin synthesis. Biochemistry 20:6594-6599
205. Freedman RB 1989 Protein disulfide isomerase: multiple roles in the modification of nascent secretory proteins. Cell 57:1069-1072
206. Noiva R, Lennarz W 1992 Minireview: protein disulfide isomerase. J Biol Chem 267:3553-3556
207. Duckworth WC 1990 Insulin degrading enzyme. In: Cuatrecasas P, Jacobs S (eds) The Handbook of Experimental Pharmacology. Springer-Verlag Press, Berlin, vol 92:143-165
208. Pease RJ, Smith GD, Peters TJ 1985 Degradation of endocytosed insulin in rat liver is mediated by low density vesicles. Biochem J 228:137-146
209. Bergeron JJM, Searle N, Khan MN, Posner BI 1986 Differential and analytical subfractionation of rat liver components internalizing insulin and prolactin. Biochemistry 25:1756-1764
210. 125I asioalofetuin degradation by the isolated, perfused rat liver and isolated rat hepatocytes. Diabetes 34:446-451
211. Roth RA, Zhang B, Chin JE, Kovacina K 1992 Substrates and signalling complexes: the tortured path to insulin action. J Cell Biochem 48:12-18
212. Kupfer S, Marschke K, Wilson E, French F 1993 Receptor accessory factor enhances specific DNA binding of androgen and glucocorticoid receptors. J Biol Chem 268:17519-17527
213. Kupfer SR, Wilson EM, French FS 1994 Androgen and glucocorticoid receptors interact with insulin degrading enzyme. J Biol Chem 269:20622-20628
214. Ali M, Plas C 1989 Glucocorticoid regulation of chloroquine non-sensitive insulin degradation in cultured fetal rat heaptocytes. J Biol Chem 264:20992-20997
215. Bennett RG, Hamel FG, Duckworth WC 1996 Insulin inhibition of fatty acid β-oxidation in isolated peroxisomes. Diabetes 45:310A
216. Tsao TC, Shi JD, Mortimore GE, Cragoe Jr EJ, Rabkin R 1990 Modulation of kidney cell protein degradation by insulin. J Lab Clin Med 116:369-376
217. Smith RM, Harada S, Jarett L 1997 Insulin internalization and other signaling pathways in the pleiotropic effects of insulin. Int Rev Cytol 173:243-280
218. Reaven GM 1995 Pathophysiology of insulin resistance in human diseases. Physiol Rev 75:473-486
219. Cheatham B, Kahn CR 1995 Insulin action and the insulin signaling network. Endocr Rev 16:117-142
220. Hofmann CA, Lotan RM, Ku WW, Oeltmann TN 1983 Insulin-ricin B hybrid molecules mediate an insulin-associated effect on cells which do not bind insulin. J Biol Chem 258:11774-11779
221. Miller DS 1989 Stimulation of protein synthesis in stage IV Xenopus oocytes by microinjected insulin. J Biol Chem 264:10438-10446
222. Miller DS 1988 Stimulation of RNA and protein synthesis by intracellular insulin. Science 240:506-509
223. Miller DS, Sykes DB 1991 Stimulation of protein synthesis by internalized insulin. J Cell Physiol 147:487-494
224. Kovacsovics-Bankowski M, Rock KL 1995 A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267:243-246
225. Draznin B, Trowbridge M 1982 Inhibition of intracellular proteolysis by insulin in isolated rat hepatocytes: possible role of internalized hormone. J Biol Chem 257:11988-11993
226. Peavy DE, Edmondson JW, Duckworth WC 1984 Selective effects of inhibitors of hormone processing on insulin action in isolated hepatocytes. Endocrinology 114:753-760
227. Hurel SJ, Rochford JJ, Borthwick AC, Wells AM, Vandenheede JR, Turnbull DM, Yeaman SJ 1996 Insulin action in cultured human myoblasts: contribution of different signalling pathways to regulation of glycogen synthesis. Biochem J 320:871-877
228. Thies RS, Ullrich A, McClain DA 1989 Augmented mitogenesis and impaired metabolic signaling mediated by a truncated insulin receptor. J Biol Chem 264:12820-12825
229. Wilden PA, Backer JM, Kahn CR, Cahill DA, Schroeder GJ, White MF 1990 The insulin receptor with phenylalanine replacing tyrosine-1146 provides evidence for separate signals regulating cellular metabolism and growth. Proc Natl Acad Sci USA 87:3358-3362
230. Yenush L, Fernandez R, Myers MG, Grammer TC, Sun XJ, Blenis J, Pierce JH, Schlessinger J, White MF 1996 The Drosophila insulin receptor activates multiple signaling pathways but requires insulin receptor substrate proteins for DNA synthesis. Mol Cell Biol 16: 2509-2517
231. Ish-Shalom D, Christoffersen CT, Vorwerk P, Sacerdoti-Sierra N, Shymko RM, Naor D, De Meyts P 1997 Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor. Diabetologia 40:525-531
232. Draznin B 1996 Editorial: Insulin signaling network - Waiting for Copernicus. Endocrinology 137:2647-2648
233. Duckworth WC, Bennett RG, Hamel FG 1994 A direct inhibitory effect of insulin on a cytosolic proteolytic complex containing insulin-degrading enzyme and multicatalycic proteinase. J Biol Chem 269:24575-24580
234. Bennett RG, Hamel FG, Duckworth WC 1997 Characterization of the insulin inhibition of the peptidolytic activities of the insulin-degrading enzyme-proteasome complex. Diabetes 46:197-203
235. Duckworth WC, Bennett RG, Hamel FG 1998 Insulin acts intracellulary on proteasomes through insulin-degrading enzyme. Biochem Biophys Res Commun 244:390-398
236. Barrett EJ, Jahn LA, Oliveras EM, Fryburg DA 1995 Chloroquine does not exert insulin-like actions on human forearm muscle metabolism. Am J Physiol 268:E820-824
237. Hamel FG, Bennett RG, Harmon KS, Duckworth WC 1997 Insulin inhibition of proteasome activity in intact cells. Biochem Biophys Res Commun 234:671-674